So yesterday Glaxo Smith Klein announced that they were going to help kids by researching worms. Yeah. WORMS.
Gross, I know, but pretty cool really. They are looking at improving access to albenzadole, which treats intestinal worms in children. Since worms are apparently a leading cause of absenteeism and poor child health, the extra 400 million doses they plan to make over the next 5 years will really help the WHO (World Health Organization.)
From a marketing perspective this is a great opportunity. It is hard to say anything negative about a company that is helping that many children!
That is some interesting but pretty gross stuff. I have heard some interesting stories though about pediatricians that could not locate the source of a child's illness and it turned out to be worms.
ReplyDelete